Replies to post #27536 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Opportunity, Moro has used patent filings to pump the stock multiple times. He made a big deal about filing an application in August 2008 but nothing ever happened.

It is a little suspicious that the stock trades for a new 52 week low and a press release follows after market close. Wed 5:21PM EDT)

It may be a coincidence but in a few weeks you should be able to see the application.

[Gold Seeker]

Opportunity stated: "Will Alere be paying their royalty payment this month?"

The date of the agreement was Decemer 4, 2007 so that would be the date in 2010 that any minimum royalty would be due. They have a month to make the payment. Be advised, in the filings, Moro has stated that he does not know when nor how any minimum royalty would be paid.

Now, there is problem. IMO, Moro violated the Alere agreement when he gave Abbott RECAF in the amended agreement for zero minimum royalties. I doubt that Alere would have to pay a minimum royalty either.

Since any minimum royalty payment would not occur until December or January 2011, you wont know or sure until the filings come out at the end of March or May 15, 2011 if the payment was made in January.

[Gold Seeker]

Opportunity, I will agree with you that the press release is interesting.

"The subject of this patent is a synthetic peptide that recognizes RECAF(TM) and that can replace the antibodies used in BioCurex's RECAF test. The synthetic peptide also allows for many other applications that cannot be performed with an antibody. BioCurex's patent application contains over 50 claims covering different applications and uses of this peptide."

If in fact, Moro has developed a unique peptide, it may be patentable. Moro has had ZERO success in gaining approval of any US patent for therapeutics in previous applications.

Constab Pharmaceuticals has been delivering anti cancer agents via RECAF but their product is not stable. It only lasts for 2 hours after formulation. If a synthetic peptide could extend that timeframe, it could make the process workable. Moro's comments are too vague to draw any positive conclusions.